Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conducting dimerized cobalt complexes with tetrathiafulvalene dithiolate ligands.
Fujiwara E, Hosoya K, Kobayashi A, Tanaka H, Tokumoto M, Okano Y, Fujiwara H, Kobayashi H, Fujishiro Y, Nishibori E, Takata M, Sakata M. Fujiwara E, et al. Among authors: hosoya k. Inorg Chem. 2008 Feb 4;47(3):863-74. doi: 10.1021/ic701100r. Epub 2008 Jan 8. Inorg Chem. 2008. PMID: 18179201
A multi-center randomized controlled trial to investigate potential effects of exercise therapy on renal function stratified by renal disorders and renal pathology: beneficial or harmful effect in immunoglobulin a nephropathy.
Kimura T, Washida N, Ohtsuki S, Sugita K, Hosoya K, Uchiyama K. Kimura T, et al. Among authors: hosoya k. Clin Exp Nephrol. 2024 Feb 25. doi: 10.1007/s10157-024-02461-2. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38402501
Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung Cancer.
Ogimoto T, Ozasa H, Tsuji T, Funazo T, Yamazoe M, Hashimoto K, Yoshida H, Hosoya K, Ajimizu H, Nomizo T, Yoshida H, Hamaji M, Menju T, Yoshizawa A, Date H, Hirai T. Ogimoto T, et al. Among authors: hosoya k. Mol Cancer Ther. 2024 Apr 2;23(4):564-576. doi: 10.1158/1535-7163.MCT-23-0371. Mol Cancer Ther. 2024. PMID: 38052760
498 results